Skip to main content
Clinical Trials/NCT00945165
NCT00945165
Completed
Not Applicable

Defining the Optimal Exercise Program to Improve Glycemic Control in Various Stages of Type 2 Diabetes.

Maastricht University Medical Center1 site in 1 country124 target enrollmentJuly 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Maastricht University Medical Center
Enrollment
124
Locations
1
Primary Endpoint
Hyperglycemia
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Hyperglycemia is an independent risk factor for the development of diabetic complications in type 2 diabetes. Exercise improves glycemic control, however, the role of exercise characteristics (e.g. intensity, type of exercise, timing, frequency) remains to be elucidated.

This study aims to assess the effect of several exercise characteristics on hyperglycemia in various subgroups of type 2 diabetes patiënts.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
June 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • BMI 25 - 35 kg/m2
  • Impaired Glucose Tolerant (according to ADA guidelines)

Exclusion Criteria

  • Cardiac disease (cardiac event in the last 5 years)
  • Type 2 diabetes
  • Use of orale blood glucose lowering medication or exogenous insulin
  • HbA1c \>10%
  • Insulin treated type 2 diabetes patients
  • Inclusion Criteria:
  • BMI 25 - 35 kg/m2
  • Insulin therapy
  • diagnosed with type 2 diabetes \>2 yr
  • Exclusion Criteria:

Outcomes

Primary Outcomes

Hyperglycemia

Time Frame: 24h

Secondary Outcomes

  • Mean Blood Glucose(24h)

Study Sites (1)

Loading locations...

Similar Trials